The Fibroblast Growth Factor (FGF) signaling pathway is reported to stimulate glioblastoma (GBM) growth. In this work we evaluated the effect of FGF2, FGF receptor (FGFR), and small molecule inhibition on GBM cells grown in traditional media, or cultured directly in stem-cell media. These lines each expressed the FGFR1, FGFR3 and FGFR4 receptors. Addition of FGF2 ligand showed significant growth stimulation in 8 of 10 cell lines. Disruption of FGF signaling by a neutralizing FGF2 monoclonal antibody and FGFR1 suppression by RNA interference both partially inhibited cell proliferation. Growth inhibition was temporally correlated with a reduction in MAPK signaling. A receptor tyrosine kinase inhibitor with known FGFR/VEGFR activity, PD173074, showed reproducible growth inhibition. Possible mechanisms of growth suppression by PD173074 were implicated by reduced phosphorylation of AKT and MAPK, known oncogenic signal transducers. Subsequent reduction in the cyclin D1, cyclin D2 and CDK4 cell cycle regulators was also observed. Our results indicate that FGF signaling pathway inhibition as a monotherapy will slow, but not arrest growth of glioblastoma cells. © Springer Science+Business Media, LLC. 2009.

Loilome, W., Joshi, A., ap Rhys, C., Piccirillo, S., Vescovi, A., Gallia, G., et al. (2009). Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling. JOURNAL OF NEURO-ONCOLOGY, 94(3), 359-366 [10.1007/s11060-009-9885-5].

Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling

VESCOVI, ANGELO LUIGI;
2009

Abstract

The Fibroblast Growth Factor (FGF) signaling pathway is reported to stimulate glioblastoma (GBM) growth. In this work we evaluated the effect of FGF2, FGF receptor (FGFR), and small molecule inhibition on GBM cells grown in traditional media, or cultured directly in stem-cell media. These lines each expressed the FGFR1, FGFR3 and FGFR4 receptors. Addition of FGF2 ligand showed significant growth stimulation in 8 of 10 cell lines. Disruption of FGF signaling by a neutralizing FGF2 monoclonal antibody and FGFR1 suppression by RNA interference both partially inhibited cell proliferation. Growth inhibition was temporally correlated with a reduction in MAPK signaling. A receptor tyrosine kinase inhibitor with known FGFR/VEGFR activity, PD173074, showed reproducible growth inhibition. Possible mechanisms of growth suppression by PD173074 were implicated by reduced phosphorylation of AKT and MAPK, known oncogenic signal transducers. Subsequent reduction in the cyclin D1, cyclin D2 and CDK4 cell cycle regulators was also observed. Our results indicate that FGF signaling pathway inhibition as a monotherapy will slow, but not arrest growth of glioblastoma cells. © Springer Science+Business Media, LLC. 2009.
Articolo in rivista - Articolo scientifico
Glioblastoma
English
2009
94
3
359
366
none
Loilome, W., Joshi, A., ap Rhys, C., Piccirillo, S., Vescovi, A., Gallia, G., et al. (2009). Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling. JOURNAL OF NEURO-ONCOLOGY, 94(3), 359-366 [10.1007/s11060-009-9885-5].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/52143
Citazioni
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 60
Social impact